Saba Capital Management, L.P. Purchases 129,372 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 129,372 shares of BlackRock Health Sciences Term Trust stock in a transaction dated Tuesday, March 26th. The shares were bought at an average price of 16.32 per share, for a total transaction of 2,111,351.04. Following the acquisition, the insider now owns 20,475,713 shares in the company, valued at 334,163,636.16. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

  • On Thursday, February 29th, Saba Capital Management, L.P. purchased 46,958 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 16.30 per share, for a total transaction of 765,415.40.
  • On Monday, February 26th, Saba Capital Management, L.P. purchased 113,930 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 16.34 per share, for a total transaction of 1,861,616.20.
  • On Thursday, February 22nd, Saba Capital Management, L.P. purchased 154,932 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 16.13 per share, for a total transaction of 2,499,053.16.
  • On Tuesday, February 20th, Saba Capital Management, L.P. acquired 193,297 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.92 per share, for a total transaction of 3,077,288.24.
  • On Thursday, February 15th, Saba Capital Management, L.P. acquired 41,462 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.82 per share, for a total transaction of 655,928.84.
  • On Monday, February 12th, Saba Capital Management, L.P. acquired 83,360 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 16.08 per share, for a total transaction of 1,340,428.80.
  • On Friday, February 9th, Saba Capital Management, L.P. acquired 122,094 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.97 per share, for a total transaction of 1,949,841.18.
  • On Wednesday, February 7th, Saba Capital Management, L.P. bought 100,354 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average cost of 15.81 per share, with a total value of 1,586,596.74.
  • On Monday, February 5th, Saba Capital Management, L.P. bought 93,967 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average cost of 15.56 per share, with a total value of 1,462,126.52.
  • On Friday, February 2nd, Saba Capital Management, L.P. acquired 53,462 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.60 per share, with a total value of 834,007.20.

BlackRock Health Sciences Term Trust Price Performance


These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Click Here To Get Your Free Copy


Shares of BlackRock Health Sciences Term Trust stock opened at 16.29 on Thursday. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.95. The business has a 50-day simple moving average of 15.94 and a 200-day simple moving average of 14.79.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Thursday, March 28th. Investors of record on Friday, March 15th will be paid a dividend of $0.09 per share. This represents a $1.08 annualized dividend and a yield of 6.63%. The ex-dividend date is Thursday, March 14th.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Several large investors have recently modified their holdings of the stock. PNC Financial Services Group Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 17.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company's stock worth $448,000 after purchasing an additional 4,604 shares during the last quarter. Virtu Financial LLC grew its holdings in BlackRock Health Sciences Term Trust by 71.2% during the fourth quarter. Virtu Financial LLC now owns 19,857 shares of the company's stock worth $291,000 after acquiring an additional 8,256 shares during the period. Citadel Advisors LLC acquired a new position in BlackRock Health Sciences Term Trust during the fourth quarter worth $431,000. Royal Bank of Canada grew its holdings in BlackRock Health Sciences Term Trust by 16.9% during the fourth quarter. Royal Bank of Canada now owns 358,116 shares of the company's stock worth $5,247,000 after acquiring an additional 51,893 shares during the period. Finally, Pathstone Holdings LLC acquired a new position in BlackRock Health Sciences Term Trust during the fourth quarter worth $222,000.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Further Reading

Insider Buying and Selling by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at BlackRock Health Sciences Term Trust?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BlackRock Health Sciences Term Trust and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles